Imagine diving into a treasure trove of medical data and uncovering invaluable insights that lead to improved outcomes for patients with brain tumors. Brain tumors, feared for their aggressiveness and low survival rates, are challenging to detect. Small lesions can easily go unnoticed, making accurate diagnosis critical. Fortunately, researchers have developed a cutting-edge solution: a hybrid deep learning model called Convolutional Neural Network-Long Short Term Memory (CNN-LSTM). By analyzing Magnetic Resonance Images (MRI), this model intelligently extracts features from images and accurately predicts brain tumors. In fact, the model achieved an astounding classification accuracy of 99.1%, with precision, recall, and F1-measure scores above 98%. With the potential to revolutionize brain tumor detection, this research paves the way for more effective therapies and increased long-term survival rates.
With the quick evolution of medical technology, the era of big data in medicine is quickly approaching. The analysis and mining of these data significantly influence the prediction, monitoring, diagnosis, and treatment of tumor disorders. Since it has a wide range of traits, a low survival rate, and an aggressive nature, brain tumor is regarded as the deadliest and most devastating disease. Misdiagnosed brain tumors lead to inadequate medical treatment, reducing the patient’s life chances. Brain tumor detection is highly challenging due to the capacity to distinguish between aberrant and normal tissues. Effective therapy and long-term survival are made possible for the patient by a correct diagnosis. Despite extensive research, there are still certain limitations in detecting brain tumors because of the unusual distribution pattern of the lesions. Finding a region with a small number of lesions can be difficult because small areas tend to look healthy. It directly reduces the classification accuracy, and extracting and choosing informative features is challenging. A significant role is played by automatically classifying early-stage brain tumors utilizing deep and machine learning approaches. This paper proposes a hybrid deep learning model Convolutional Neural Network-Long Short Term Memory (CNN-LSTM) for classifying and predicting brain tumors through Magnetic Resonance Images (MRI). We experiment on an MRI brain image dataset. First, the data is preprocessed efficiently, and then, the Convolutional Neural Network (CNN) is applied to extract the significant features from images. The proposed model predicts the brain tumor with a significant classification accuracy of 99.1%, a precision of 98.8%, recall of 98.9%, and F1-measure of 99.0%.
Dr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, where he leads the charge in pioneering Self-Enhancement Science for the Success of Society. With a keen interest in exploring the untapped potential of the human mind, Dr. Lowemann has dedicated his career to pushing the boundaries of human capabilities and understanding.
Armed with a Master of Science degree and a Ph.D. in his field, Dr. Lowemann has consistently been at the forefront of research and innovation, delving into ways to optimize human performance, cognition, and overall well-being. His work at the Institute revolves around a profound commitment to harnessing cutting-edge science and technology to help individuals lead more fulfilling and intelligent lives.
Dr. Lowemann’s influence extends to the educational platform BetterSmarter.me, where he shares his insights, findings, and personal development strategies with a broader audience. His ongoing mission is shaping the way we perceive and leverage the vast capacities of the human mind, offering invaluable contributions to society’s overall success and collective well-being.